Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice
Lionel M. Igaz, … , John Q. Trojanowski, Virginia M.-Y. Lee
Lionel M. Igaz, … , John Q. Trojanowski, Virginia M.-Y. Lee
Published January 4, 2011
Citation Information: J Clin Invest. 2011;121(2):726-738. https://doi.org/10.1172/JCI44867.
View: Text | PDF
Research Article Neuroscience Article has an altmetric score of 11

Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice

  • Text
  • PDF
Abstract

Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are characterized by cytoplasmic protein aggregates in the brain and spinal cord that include TAR-DNA binding protein 43 (TDP-43). TDP-43 is normally localized in the nucleus with roles in the regulation of gene expression, and pathological cytoplasmic aggregates are associated with depletion of nuclear protein. Here, we generated transgenic mice expressing human TDP-43 with a defective nuclear localization signal in the forebrain (hTDP-43-ΔNLS), and compared them with mice expressing WT hTDP-43 (hTDP-43-WT) to determine the effects of mislocalized cytoplasmic TDP-43 on neuronal viability. Expression of either hTDP-43-ΔNLS or hTDP-43-WT led to neuron loss in selectively vulnerable forebrain regions, corticospinal tract degeneration, and motor spasticity recapitulating key aspects of FTLD and primary lateral sclerosis. Only rare cytoplasmic phosphorylated and ubiquitinated TDP-43 inclusions were seen in hTDP-43-ΔNLS mice, suggesting that cytoplasmic inclusions were not required to induce neuronal death. Instead, neurodegeneration in hTDP-43 and hTDP-43-ΔNLS–expressing neurons was accompanied by a dramatic downregulation of the endogenous mouse TDP-43. Moreover, mice expressing hTDP-43-ΔNLS exhibited profound changes in gene expression in cortical neurons. Our data suggest that perturbation of endogenous nuclear TDP-43 results in loss of normal TDP-43 function(s) and gene regulatory pathways, culminating in degeneration of selectively vulnerable affected neurons.

Authors

Lionel M. Igaz, Linda K. Kwong, Edward B. Lee, Alice Chen-Plotkin, Eric Swanson, Travis Unger, Joe Malunda, Yan Xu, Matthew J. Winton, John Q. Trojanowski, Virginia M.-Y. Lee

×

Figure 3

Cytoplasmic hTDP-43 expression and progressive neuronal loss in tTA/TDP-ΔNLS mice.

Options: View larger image (or click on image) Download as PowerPoint
Cytoplasmic hTDP-43 expression and progressive neuronal loss in tTA/TDP-...
(A–D) Progressive neuron loss in tTA/TDP-ΔNLS4 mice. Hippocampal H&E sections of nTg (A) and tTA/TDP-ΔNLS (B) mice show a progressive DG neuron loss evident from 1 month off Dox (arrowhead highlights DG degeneration). (E–J) Cytoplasmic TDP-43 expression in tTA/TDP-ΔNLS hippocampus. IHC for hTDP-43 (E–G) or h+m TDP-43 (H–J) was performed on hippocampal sections from bigenic mice 1 week off Dox showing predominantly cytoplasmic expression of TDP-43. Insets show nTg mice with no hTDP-43 expression and nuclear h+mTDP-43 expression. Scale bars: 500 μm; (A–D, E and H); 200 μm (F, G, I, and J). (K) Loss of DG neurons in tTA/TDP-ΔNLS4 mice. Quantification of DG neurons shows progressive neuronal loss in tTA/TDP-ΔNLS mice. Data shown represent mean ± SEM (n = 3–4 per group). *Significantly different from nTg (P < 0.001). (L) Immunoblot analysis of enriched cytoplasmic (C) and nuclear (N) fractions isolated from cortical extracts of monogenic tTA and 2-month-old bigenic tTA/TDP-ΔNLS mice 10 days off Dox showing the presence of hTDP-43 in both fractions in tTA/TDP-ΔNLS. Note endogenous mTDP-43 is predominately nuclear. Nuclear hnRNP A2/B1 and cytoplasmic HSP90 indicated that the fractions are well separated.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 1
Referenced in 6 patents
403 readers on Mendeley
See more details